Xanthorrhizol: a Review of Its Pharmacological Activities and Anticancer Properties

Overview

Journal Cancer Cell Int

Publisher Biomed Central

Date 2015 Oct 27

PMID 26500452

Citations 29

Authors

Seok Fang Oon

Meenakshii Nallappan

Thiam Tsui Tee

Shamarina Shohaimi

Nur Kartinee Kassim

Mohd Shazrul Fazry Saariwijaya

Yew Hoong Cheah

Affiliations

Soon will be listed here.

Abstract

Xanthorrhizol (XNT) is a bisabolane-type sesquiterpenoid compound extracted from Curcuma xanthorrhiza Roxb. It has been well established to possess a variety of biological activities such as anticancer, antimicrobial, anti-inflammatory, antioxidant, antihyperglycemic, antihypertensive, antiplatelet, nephroprotective, hepatoprotective, estrogenic and anti-estrogenic effects. Since many synthetic drugs possess toxic side effects and are unable to support the increasing prevalence of disease, there is significant interest in developing natural product as new therapeutics. XNT is a very potent natural bioactive compound that could fulfil the current need for new drug discovery. Despite its importance, a comprehensive review of XNT's pharmacological activities has not been published in the scientific literature to date. Here, the present review aims to summarize the available information in this area, focus on its anticancer properties and indicate the current status of the research. This helps to facilitate the understanding of XNT's pharmacological role in drug discovery, thus suggesting areas where further research is required.

Citing Articles

Ultrasonic-assisted extraction (UAE) of Javanese turmeric rhizomes using natural deep eutectic solvents (NADES): Screening, optimization, and in vitro cytotoxicity evaluation.

Ariestanti D, Munim A, Hartrianti P, Nadia B, Chriscensia E, Rattu S Ultrason Sonochem. 2025; 114:107271.

PMID: 39955874 PMC: 11872070. DOI: 10.1016/j.ultsonch.2025.107271.

The efficacy of the food-grade antimicrobial xanthorrhizol against is associated with McsL channel expression.

Mordukhova E, Kim J, Jin H, No K, Pan J Front Microbiol. 2024; 15:1439009.

PMID: 39021623 PMC: 11251944. DOI: 10.3389/fmicb.2024.1439009.

extract and xanthorrhizol ameliorate cancer-induced adipose wasting in CT26-bearing mice by regulating lipid metabolism and adipose tissue browning.

Kim H, Lee D, Hwang J Integr Med Res. 2024; 13(1):101020.

PMID: 38298864 PMC: 10826318. DOI: 10.1016/j.imr.2023.101020.

L.-Review of a Traditional Mediterranean Medicinal Plant with Pharmacological Potential.

Raus de Baviera D, Ruiz-Canales A, Barrajon-Catalan E Plants (Basel). 2023; 12(16).

PMID: 37631199 PMC: 10458491. DOI: 10.3390/plants12162988.

Computational evaluation of bioactive compounds in targeting SIRT1 and NFκB.

Prasetyawan S, Safitri A, Athoillah M, Rahayu S BioTechnologia (Pozn). 2023; 104(2):171-182.

PMID: 37427032 PMC: 10323740. DOI: 10.5114/bta.2023.127206.

References

Yamazaki M, Maebayashi Y, Iwase N, Kaneko T . Studies on pharmacologically active principles from Indonesian crude drugs. I. Principle prolonging pentobarbital-induced sleeping time from Curcuma xanthorrhiza Roxb. Chem Pharm Bull (Tokyo). 1988; 36(6):2070-4. DOI: 10.1248/cpb.36.2070. View

Chung W, Park J, Kim M, Kim H, Hwang J, Lee S . Xanthorrhizol inhibits 12-O-tetradecanoylphorbol-13-acetate-induced acute inflammation and two-stage mouse skin carcinogenesis by blocking the expression of ornithine decarboxylase, cyclooxygenase-2 and inducible nitric oxide synthase through.... Carcinogenesis. 2007; 28(6):1224-31. DOI: 10.1093/carcin/bgm005. View

Noomhorm N, Chang C, Wen C, Wang J, Chen J, Tseng L . In vitro and in vivo effects of xanthorrhizol on human breast cancer MCF-7 cells treated with tamoxifen. J Pharmacol Sci. 2014; 125(4):375-85. DOI: 10.1254/jphs.14024fp. View

Cummings J, Ward T, Ranson M, Dive C . Apoptosis pathway-targeted drugs--from the bench to the clinic. Biochim Biophys Acta. 2004; 1705(1):53-66. DOI: 10.1016/j.bbcan.2004.09.005. View

Wilken R, Veena M, Wang M, Srivatsan E . Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma. Mol Cancer. 2011; 10:12. PMC: 3055228. DOI: 10.1186/1476-4598-10-12. View

Frohlich E . Current challenges in clinical research. Ochsner J. 2011; 6(1):10-1. PMC: 3127480. View

Madias N, Harrington J . Platinum nephrotoxicity. Am J Med. 1978; 65(2):307-14. DOI: 10.1016/0002-9343(78)90825-2. View

Rukayadi Y, Yong D, Hwang J . In vitro anticandidal activity of xanthorrhizol isolated from Curcuma xanthorrhiza Roxb. J Antimicrob Chemother. 2006; 57(6):1231-4. DOI: 10.1093/jac/dkl132. View

Miyashita T, Krajewski S, Krajewska M, Wang H, Lin H, Liebermann D . Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene. 1994; 9(6):1799-805. View

10.

Cheah Y, Nordin F, Sarip R, Tee T, Azimahtol H, Sirat H . Combined xanthorrhizol-curcumin exhibits synergistic growth inhibitory activity via apoptosis induction in human breast cancer cells MDA-MB-231. Cancer Cell Int. 2009; 9:1. PMC: 2630298. DOI: 10.1186/1475-2867-9-1. View

11.

Salea R, Widjojokusumo E, Veriansyah B, Tjandrawinata R . Optimizing oil and xanthorrhizol extraction from Curcuma xanthorrhiza Roxb. rhizome by supercritical carbon dioxide. J Food Sci Technol. 2014; 51(9):2197-203. PMC: 4152541. DOI: 10.1007/s13197-014-1272-3. View

12.

Rukayadi Y, Han S, Yong D, Hwang J . In vitro activity of xanthorrhizol against Candida glabrata, C. guilliermondii, and C. parapsilosis biofilms. Med Mycol. 2010; 49(1):1-9. DOI: 10.3109/13693786.2010.492482. View

13.

Naglik J, Richardson J, Moyes D . Candida albicans pathogenicity and epithelial immunity. PLoS Pathog. 2014; 10(8):e1004257. PMC: 4133391. DOI: 10.1371/journal.ppat.1004257. View

14.

Baek S, Kim K, Nixon J, Wilson L, Eling T . Cyclooxygenase inhibitors regulate the expression of a TGF-beta superfamily member that has proapoptotic and antitumorigenic activities. Mol Pharmacol. 2001; 59(4):901-8. View

15.

Tham D, Gardner C, Haskell W . Clinical review 97: Potential health benefits of dietary phytoestrogens: a review of the clinical, epidemiological, and mechanistic evidence. J Clin Endocrinol Metab. 1998; 83(7):2223-35. DOI: 10.1210/jcem.83.7.4752. View

16.

Lim C, Jin D, Mok H, Oh S, Lee J, Hwang J . Antioxidant and antiinflammatory activities of xanthorrhizol in hippocampal neurons and primary cultured microglia. J Neurosci Res. 2005; 82(6):831-8. DOI: 10.1002/jnr.20692. View

17.

Cheah Y, Azimahtol H, Abdullah N . Xanthorrhizol exhibits antiproliferative activity on MCF-7 breast cancer cells via apoptosis induction. Anticancer Res. 2007; 26(6B):4527-34. View

18.

Bottone Jr F, Baek S, Nixon J, Eling T . Diallyl disulfide (DADS) induces the antitumorigenic NSAID-activated gene (NAG-1) by a p53-dependent mechanism in human colorectal HCT 116 cells. J Nutr. 2002; 132(4):773-8. DOI: 10.1093/jn/132.4.773. View

19.

Jo H, Zhang R, Zhang H, McKinsey T, Shao J, Beauchamp R . NF-kappa B is required for H-ras oncogene induced abnormal cell proliferation and tumorigenesis. Oncogene. 2000; 19(7):841-9. DOI: 10.1038/sj.onc.1203392. View

20.

Lee S, Kim S, Oh O, Min H, Park K, Chung W . Suppressive effect of natural sesquiterpenoids on inducible cyclooxygenase (COX-2) and nitric oxide synthase (iNOS) activity in mouse macrophage cells. J Environ Pathol Toxicol Oncol. 2002; 21(2):141-8. View